Figure 2 | Scientific Reports

Figure 2

From: Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy

Figure 2The alternative text for this image may have been generated using AI.

Biomarkers concordance rates between CNB and surgery. (A) Concordance rates for ER, PR, HER2, and Ki-67 between DCIS at CNB and surgery in patients without pathological underestimation. (B) Concordance rates for ER, PR, HER2, and Ki-67 between DCIS at CNB and in situ components at surgery in patients with pathological underestimation. (C) Concordance rates for ER, PR, HER2, and Ki-67 between DCIS at CNB and invasive components at surgery in patients with pathological underestimation. (D) Concordance rates for ER, PR, HER2, and Ki-67 between in situ components and invasive components at surgery in patients with pathological underestimation. DCIS ductal carcinoma in situ, CNB core needle biopsy, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2, Ki-67 proliferation index.

Back to article page